News
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...
FRANKFURT (Reuters) -German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
BioNTech stock was rising after the drugmaker reported better-than-expected results on Monday. In early trading, the ...
17h
Zacks.com on MSNPfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth
PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...
The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...
A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.
3d
The Manila Times on MSNPfizer and BioNTech lose UK court appeal over Covid-19 jab
Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...
Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...
BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...
16d
TheHealthSite on MSNPfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?
BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results